Status:
COMPLETED
Efficacy and Safety of Corticosteroids in COVID-19
Lead Sponsor:
Beijing Chao Yang Hospital
Conditions:
COVID-19
Novel Coronavirus Pneumonia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There is still controversy about the effective of glucocorticoids for the treatment of novel coronavirus pneumonia. This is a prospective randomized controlled trails. The aim is to explore the effect...
Eligibility Criteria
Inclusion
- age more than 18 years old
- accord with the clinical diagnosis and/ or etiological diagnosis diagnostic criteria of Novel coronavirus pneumonia (COVID-19).
- admitted in the general wards
- be able to sign informed consent
Exclusion
- severe immunosuppression (HIV infection, long-term use of immunosuppressive agents
- pregnant or lactation period women
- glucocorticoids are needed for other diseases
- unwilling or unable to participate or complete the study
- participate in other study
Key Trial Info
Start Date :
February 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 15 2020
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT04273321
Start Date
February 14 2020
End Date
April 15 2020
Last Update
May 11 2020
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Hubei province hospital of integrated Chinese & Western Medicine
Wuhan, Hubei, China
2
Yichang first people's Hospital
Yichang, Hubei, China
3
Beijing YouAn Hospital
Beijing, China
4
Renmin Hospital of Wuhan University
Wuhan, China